Godfrey Phillips India

What Godfrey Phillips India does

Godfrey Phillips India (GPI) is one of India's largest FMCG companies and the flagship entity of Modi Enterprises under the KK Modi Group, operating primarily as a cigarette manufacturer and distributor. Founded in 1936 and headquartered in Jasola, New Delhi, GPI manufactures and distributes owned cigarette brands (Four Square, Red and White, Cavanders) and licenses the globally iconic Marlboro brand from Philip Morris Global Brands Inc., serving adult Indian tobacco consumers across all price segments from premium king-size variants to value pocket-packs. The company reaches over 1.3 crore retail outlets through its own distribution network and holds the position of India's second-largest cigarette manufacturer after ITC.

Beyond cigarettes, GPI operates a Leaf Division trading unmanufactured tobacco for domestic procurement (notably as a major off-taker of Virginia tobacco in Andhra Pradesh) and international export, and has diversified into confectionery. In May 2026 the company signed two significant agreements: a 9-year exclusive contract manufacturing pact with Polisetty Somasundaram Tobacco Products to augment production capacity, and a three-year distribution deal with Aspeya India (a Philip Morris Global Brands entity) for nicotine replacement therapy products, marking entry into smoking-cessation adjacencies.

GPI is publicly listed on NSE and BSE (ticker: GODFRYPHLP) under Modi family control, with Bina Modi as Chairperson and Managing Director and Philip Morris-affiliated board representation. The company reported FY26 consolidated revenue from operations of Rs 6,352.63 crore (up 13.88% year-on-year) and net profit of Rs 1,526 crore (up 42.35%), supported by 20% volume growth and EBITDA margin expansion to roughly 31%. Following the February 2026 excise duty hike, GPI implemented pack-level price increases of Rs 22-55 across brands, with Pocket Marlboro rising from Rs 70 to Rs 85. The company faces structural headwinds from illicit trade estimated at ~26% of India's total tobacco market and ongoing family-related governance matters, but its licensed status, distribution depth, and pricing power have delivered outsized FY26 financial performance, including a recommended Rs 33 per share dividend.

Name

Godfrey Phillips India

Legal name

Godfrey Phillips India Ltd.

Website

https://godfreyphillips.com

Company type

Public

Founded year

1836

Operating status

Operating

Headcount range

1,001–5,000 employees

Short description

Godfrey Phillips India is India's second-largest cigarette manufacturer and flagship of the KK Modi Group, producing owned brands (Four Square, Red and White, Cavanders) and distributing Marlboro under Philip Morris license across 1.3 crore+ Indian retail outlets.

Ownership category

akta.pro rank

Product category

Tobacco Products

NAICS

Tobacco Manufacturing (3122), Tobacco Manufacturing (312230)

SIC

Cigarettes (2111), Tobacco Products (2100)

akta.pro primary industry

Cigarettes Manufacturing & Brands (CRADAJAA)

Keywords

• Cigarette manufacturing
• Tobacco products
• Tobacco leaf trading
• FMCG distribution
• Nicotine replacement therapy

Headquarters

HQ city

New Delhi

HQ country

India

HQ region

Asia

Offices1 record

Markets served

GTM type

B2C

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Marketing or Sales, Personnel, Technology or R&D, Infrastructure

Revenue model

1. Cigarette Manufacturing & Sales: Core revenue stream from manufacturing and selling cigarettes including owned brands (Four Square, Red and White, Cavanders) and licensed Marlboro brands distributed under Philip Morris license agreement. Revenue grew 13.88% to Rs 6,352.63 crore for FY26.
2. Unmanufactured Tobacco & Leaf Division: Export and domestic sale of unmanufactured tobacco leaf, operating through the Leaf Division. Subject to export dynamics and domestic procurement, with the company being a major off-taker of Virginia tobacco in Andhra Pradesh.
3. Confectionery: Business ranges include confectionery products as part of the broader FMCG portfolio.
4. Nicotine Replacement Therapy Products: Distribution of nicotine replacement therapy products under a three-year distribution agreement with Aspeya India (member entity of Philip Morris Global Brands Inc).

Pricing tiers

Go-to-market motion1 record

Distribution channels3 records

Marketing channels2 records

Core offering

Godfrey Phillips India manufactures and distributes cigarettes in India, including its owned brands (Four Square, Red and White, Cavanders) and the globally licensed Marlboro brand under agreement with Philip Morris Global Brands Inc. The company also trades unmanufactured tobacco leaf through its Leaf Division for domestic and international markets, has a confectionery line, and distributes nicotine replacement therapy products under partnership with Aspeya India.

Product overview

Godfrey Phillips India is a diversified FMCG company primarily engaged in the manufacture and distribution of cigarettes and tobacco products. The company's core product portfolio includes owned brands (Four Square, Red and White, Cavanders) and licensed premium brand Marlboro distributed under agreement with Philip Morris Global Brands Inc. Beyond cigarettes, the company operates a Leaf Division trading unmanufactured tobacco for domestic and international markets, and has diversified into confectionery products. A recent strategic expansion includes distribution of Nicotine Replacement Therapy (NRT) products under a partnership with Aspeya India/Philip Morris Global Brands Inc. The company operates world-class manufacturing facilities and maintains a strong distribution network across India.

Differentiator

Problem solved

Functional benefit

Brands

• Marlboro: Premium cigarette brand distributed under license agreement with Philip Morris
• Four Square
• Red and White
• Cavanders

Products and services

• Marlboro Cigarettes
• Four Square Cigarettes
• Red and White Cigarettes
• Cavanders Cigarettes
• Unmanufactured Tobacco Leaf
• Confectionery Products
• Nicotine Replacement Therapy (NRT) Products

Quantifiable outcome

• Q4 FY26 net profit up 86% YoY to Rs 521.46 crore with EBITDA margin expanding to 31%
• +3 more outcomes

Named customers2 records

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Three partnerships are on record, tiered core, strategic and flagship.

• Polisetty Somasundaram Tobacco Products (India) Private LimitedcoreStrategic or Co-development Partner · 27 May 2026Godfrey Phillips India signed a 9-year contract manufacturing agreement with Polisetty Somasundaram Tobacco Products (India) Private on May 27, 2026. Under this agreement, Polisetty will manufacture cigarettes and tobacco products exclusively for Godfrey Phillips at its facility. Polisetty has up to 12 months to set up the manufacturing facility and obtain required licenses. Godfrey Phillips will pay a manufacturing fee and may provide equipment on a bailment basis. The agreement will augment production capacity and ensure uninterrupted product availability, and does not qualify as a related party transaction.
• Aspeya India Pvt Ltd (Member entity of Philip Morris Global Brands Inc)strategicChannel Partner/ Reseller/ Distributor · 15 May 2026Godfrey Phillips India's board approved a three-year distribution agreement with Aspeya India Pvt Ltd, a member entity of Philip Morris Global Brands Inc, for nicotine replacement therapy (NRT) products. This expands the company's product portfolio beyond traditional cigarettes into smoking cessation products under the Philip Morris ecosystem.
• Philip Morris Global Brands IncflagshipOEM/ Whitelabel/ Licensing PartnerGodfrey Phillips India manufactures and distributes Marlboro brand cigarettes in India under a license agreement with Philip Morris Global Brands Inc. This is the company's flagship licensing partnership covering premium pocket-pack cigarettes (Pocket Marlboro) and other Marlboro variants. The partnership also extends to nicotine replacement therapy product distribution via Aspeya India.

Scale indicators12 records

Recent moves5 records

Expansion highlights4 records

Broad incumbents

• Altria Group: Altria Group is a leading US tobacco company (Marlboro US, Philip Morris USA) with comparable cigarette manufacturing and reduced-risk product strategies. Useful as a global tobacco industry comparable.
• Japan Tobacco International: Japan Tobacco International is a major global tobacco manufacturer with broad geographic presence and similar product portfolio. Operates across the same industry value chain and faces comparable regulatory pressures.
• British American Tobacco: British American Tobacco is a global tobacco giant with significant operations in multiple markets. Indirectly comparable as a global tobacco manufacturer facing similar regulatory and illicit-trade dynamics, though not a direct India competitor.
• Philip Morris International: Philip Morris International is GPI's licensor for Marlboro and NRT distribution, and one of the world's largest cigarette manufacturers. Operates globally with a broader portfolio including reduced-risk products, and has board representation at GPI via Marco Mariotti.

Direct peers

• NTC Industries Limited: NTC Industries is an Indian tobacco and cigarette company operating in similar product and regulatory territory. Smaller scale but directly comparable business model in the Indian market.
• ITC Limited: ITC Limited is India's largest cigarette manufacturer (Gold Flake, Classic, etc.), directly competing with GPI across price segments and controlling 45-50% of state tobacco purchases. Same regulatory environment, same distribution channels, same product category.
• Golden Tobacco Limited: Golden Tobacco is a smaller Indian cigarette manufacturer with overlapping product portfolio and direct competition in the Indian cigarette market. Comparable regulatory and excise exposure.
• VST Industries: VST Industries is another major Indian cigarette manufacturer (Charms, Charminar) with comparable distribution and regulatory exposure. Smaller scale than GPI but operates in the same product category and channels.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/GodfreyPhillipsIndia
• LinkedInlinkedin.com/company/godfrey-phillips-india

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Godfrey Phillips India